UniProt ID | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs ▲ | Disease Ontology |
---|---|---|---|---|---|
B0AZP8 | cDNA, FLJ79488, highly similar to Homo sapiens solute carrier family 43, member 3 (SLC43A3), mRNA |
|
1 | 0 |
|
G1EQ55 | MHC class I antigen (Fragment) |
|
1 | 0 |
|
P07741 | Adenine phosphoribosyltransferase |
|
1 | 0 | |
O43557 | Tumor necrosis factor ligand superfamily member 14 |
|
1 | 0 |
|
Q9UKK6 | NTF2-related export protein 1 |
|
1 | 0 |
|
O00257 | E3 SUMO-protein ligase CBX4 |
|
1 | 0 | |
Q59GS8 | Complement component 5 variant (Fragment) |
|
1 | 0 |
|
A0A0A0MR67 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A0A7C4Q9 | MHC class I antigen (Fragment) |
|
1 | 0 |
|
A0A493QP75 | MHC class I antigen |
|
1 | 0 |
|
W1EBQ9 | MHC class I antigen (Fragment) |
|
1 | 0 |
|
A0A288R1F2 | MHC class I antigen (Fragment) |
|
1 | 0 |
|
P30550 | Gastrin-releasing peptide receptor |
|
1 | 0 |
|
R4GMX5 | Basigin (Fragment) |
|
1 | 0 |
|
B2R728 | cDNA, FLJ93255, highly similar to Homo sapiens solute carrier family 7 (cationic amino acidtransporter, y+ system), member 1 (SLC7A1), mRNA |
|
1 | 0 |
|
M0R3C9 | Notch receptor 3 (Fragment) |
|
1 | 0 |
|
L0HNE1 | MHC class I antigen (Fragment) |
|
1 | 0 |
|
O95868 | Lymphocyte antigen 6 complex locus protein G6d |
|
2 | 0 |
|
H0YK59 | CD276 molecule (Fragment) |
|
2 | 0 |
|
C9WCT0 | MHC class I antigen (Fragment) |
|
1 | 0 |
|
A0A1C3PHQ8 | MHC class I antigen |
|
1 | 0 |
|
Q8NFN8 | Probable G-protein coupled receptor 156 |
|
1 | 0 | |
E9PRS3 | Serpin family H member 1 (Fragment) |
|
2 | 0 |
|
I6M555 | MHC class I antigen (Fragment) |
|
1 | 0 |
|
Q96L15 | Ecto-ADP-ribosyltransferase 5 |
|
3 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025